obinutuzumab

Ukraine

Medications containing this active substance

Gaziva

Form: concentrate for infusion solution

Active substance	Dosage
obinutuzumab	25 mg/ml

Manufacturer: F. Hoffmann-La Roche Ltd (batch release; secondary packaging)